ADCDaily

A daily compilation of articles, manuscripts, and news focused on the ADC market and compiled for the scientists who are making the cure everyday.

Labels

  • 5 Things Articles
  • ADC Links
  • ADC News
  • Featured Articles
  • Industry
  • Manuscripts
  • Regulatory

Thursday, May 16, 2019

Daiichi gets one out of two drugs approved


In case you hadn't already heard about this.  Now you have:

https://endpts.com/daiichi-sankyo-disappointed-as-fda-experts-spurn-aml-drug-but-vote-in-favor-of-rare-tumor-drug/

https://www.reuters.com/article/us-daiichi-sankyo-fda/fda-advisory-panel-votes-against-daiichi-sankyos-cancer-treatment-idUSKCN1SK2JP
https://www.fiercebiotech.com/biotech/daiichi-s-leukemia-drug-falls-amid-fda-adcomm-s-trial-concerns
https://finance.yahoo.com/news/daiichi-sankyo-announces-outcome-fda-220200236.html
https://www.biospace.com/article/daiichi-sankyo-receives-a-yes-and-no-from-fda-advisory-panel/
https://www.evaluate.com/vantage/articles/news/snippets/us-backs-only-one-two-daiichi-oncology-projects-only-beginning

Wow.
By Justin Sweeley
Email ThisBlogThis!Share to TwitterShare to FacebookShare to Pinterest
Labels: ADC News, Industry, Regulatory

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)
  • New Here?
    Read Me!!!

Search This Blog

Blog Archive

  • January 2020 (2)
  • November 2019 (1)
  • October 2019 (4)
  • September 2019 (2)
  • August 2019 (4)
  • July 2019 (5)
  • June 2019 (5)
  • May 2019 (43)
  • April 2019 (30)

Most Popular

  • Update - June 19th, 2019
  • 3D Printed Organs are becoming Real.
  • Organic Synthesis in ADCs
  • Nobody wants this much info from the FDA, but you NEED it

Comments?
Send us a message directly

Name

Email *

Message *

Report Abuse

About the Author

My photo
Justin Sweeley
View my complete profile
Awesome Inc. theme. Powered by Blogger.